Screening and prevention of hepatitis C virus reactivation during chemotherapy

doi:10.3748/wjg.v27.i31.5181

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 27, Issue 31

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6037)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

406

WORD

113

HTML

3362

Figures (1-1)

277

Tables (1-3)

409

Sum=4567

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

526

Download

944

Sum=1470

Aug 21, 2021 (publication date) through Jul 21, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Gastroenterol. Aug 21, 2021; 27(31): 5181-5188
Published online Aug 21, 2021. doi: 10.3748/wjg.v27.i31.5181

Open in New Tab Full Size Figure Download Figure

Figure 1 Current recommendations for testing and treating hepatitis C virus infection in cancer patients receiving chemotherapy. HCV: Hepatitis C virus; DAA: Direct-acting antiviral.

Citation: Li YR, Hu TH, Chen WC, Hsu PI, Chen HC. Screening and prevention of hepatitis C virus reactivation during chemotherapy. World J Gastroenterol 2021; 27(31): 5181-5188
URL: https://www.wjgnet.com/1007-9327/full/v27/i31/5181.htm
DOI: https://dx.doi.org/10.3748/wjg.v27.i31.5181